News
Stocktwits on MSN51m
Genmab Stock Rises On Strong Darzalex Sales In Q1: Retail Remains Extremely BullishNasdaq-listed American Depository Receipts (ADRs) of Genmab A/S (GMAB) rose over 1% on Thursday morning after Johnson & Johnson (JNJ)announced that sales of the oncology drug Darzalex rose over 20% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback